Neurology Minute

In the October episode of the President's Spotlight, Dr. Jason Crowell talks with Dr. Natalia Rost about the crucial role research plays in neurology for clinicians and scientists.  Show reference:  https://www.aan.com/about-the-aan/presidents-spotlight 

In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from October 6th, covering the government shutdown and its potential impact on you and your patients.  Stay updated with what’s happening on the hill by visiting aan.com/chr.  Take a minute to email your members of Congress and ensure your voice is heard! 

In the second episode of this two-part series, Dr. Kiran Thakur and Dr. Ava Easton discuss how to get involved in advocacy efforts and policy development related to encephalitis.  Show reference: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00057-6/fulltext 

In part one of this two-part series, Dr. Kiran Thakur and Dr. Ava Easton discuss the World Health Organization's technical brief on encephalitis.  Show reference: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00057-6/fulltext  

In the third episode of this five-part series, Dr. Paul Crane discusses measles inclusion body encephalitis.     

In the second part of this five-part series, Dr. Paul Crane discusses the early neurologic complications associated with measles.   

In the first part of this five-part series, Dr. Paul Crane discusses the reemergence of measles and outlines steps to take if you suspect someone may have measles. 

In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from September 8, providing important updates around BrainPAC. Stay updated with what’s happening on the hill by visiting aan.com/chr.  Learn how you can get involved with AAN advocacy. 

Dr. Deanna Saylor and Dr. Senjuti Saha discuss colonialism in global health and the importance of pathogen genomics.  Show reference:  https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00091-8/fulltext

In the final episode of this two-part series, Dr. Justin Abbatemarco discusses long-term maintenance therapy options.  Show reference:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200504 

In part one of this two-part series, Dr. Justin Abbatemarco discusses what we know and don't know surrounding MOG antibody–associated diseases (MOGADs).  Show reference:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200504 

In the final part of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss how to approach discontinuation of immunotherapy in clinical practice.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213903   

In part two of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss a long-term maintenance approach for MOGAD.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213903  

In part two of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the future of addressing intolerable suffering in practice and explore the opportunities for MAID.  Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478 

In part one of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the main takeaway points from the paper.  Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478

In part one of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213903 

Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis.  Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext

Dr. Bradley Ong discusses the efficacy and safety of fremanezumab in adults with migraine and comorbid major depressive disorder. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2833452 

In part two of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss ways to empower professionals in the fields of neurology and research. 

In the first part of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss strategies for advancing the fields of neurology and neuroscience research.